AZD6482: From PI3Kβ Mechanism to Translation
2026-09-08
AZD6482 offers a selective way to interrogate PI3Kβ in platelet, metabolic, and pathway-signaling studies. This thought-leadership analysis connects its established pharmacology with disciplined translational strategy, including a carefully bounded exploratory bridge to DM1 RNA-foci research.
Roscovitine at the Radiotherapy–Immunity Interface
2026-09-07
Roscovitine, also known as Seliciclib or CYC202, offers a reversible way to interrogate cyclin-dependent kinase signaling alongside radiotherapy and immune checkpoint strategies. This thought-leadership analysis connects its cell-cycle mechanism with recent evidence for radiotherapy, PD-1, and TIGIT blockade while distinguishing validated findings from forward-looking translational hypotheses.
SAR131675: VEGFR-3 Inhibitor Assay Guide
2026-09-05
A scenario-based guide to using SAR131675, a selective and ATP-competitive VEGFR-3 inhibitor, in viability, signaling, migration, and fibrosis-related experiments. It explains how SKU B2301 potency, selectivity, formulation constraints, and published evidence can improve assay interpretation and experimental planning.
Thapsigargin: SERCA Pump Inhibitor Workflow
2026-09-05
Thapsigargin enables controlled separation of acute calcium mobilization from sustained endoplasmic reticulum stress and apoptosis. This practical guide connects calcium imaging, stress-response profiling, and glioblastoma resistance studies to help researchers select informative doses, time points, controls, and troubleshooting strategies.
Dimetridazole BA1077: Reliable Assay Design
2026-09-04
Learn how Dimetridazole (SKU BA1077) can improve interpretation of bacterial culture, quorum-sensing, biofilm, and infection-model assays without confusing antivirulence activity with direct cytotoxicity. This scenario-based guide covers controls, solvent compatibility, protocol parameters, data interpretation, and practical reagent selection.
Cinoxacin Workflows for Gram-Negative Research
2026-09-04
Cinoxacin provides a focused in vitro benchmark for gram-negative aerobic bacteria, urinary tract infection research, and antibiotic resistance studies. This guide converts historical agar, broth, disk-diffusion, and bactericidal findings into practical workflows with assay-selection and troubleshooting guidance.
(-)-Blebbistatin for Myosin II Assays
2026-09-03
(-)-Blebbistatin enables reversible, concentration-guided control of non-muscle myosin II for live-cell mechanics, migration, adhesion, and contractility experiments. This workflow-focused guide connects actomyosin perturbation with temperature-sensitive cardiac electrophysiology while clearly separating validated mechanisms from practical assay extensions.
Crystal Violet Staining Solution: Biomass to Biology
2026-09-03
Crystal Violet Staining Solution is more than a purple endpoint: it reports retained cellular or biofilm-associated material. This evidence-led guide explains how to interpret the nuclear staining dye alongside metabolic assays, with practical decisions grounded in antimicrobial biofilm research.
Trilaurin Workflow: Solubility, QC, and Use
2026-09-02
Trilaurin, also called Glycerol Tridodecanoate, is a water-insoluble C12 triacylglycerol used as a lipid excipient, enzyme substrate, and formulation component. This guide explains solvent selection, preparation, controls, and quality checks while defining where dossier-level evidence should not be generalized to biological efficacy or clinical performance.
Dimetridazole: Reliable Assay Design with BA1077
2026-09-02
Learn how Dimetridazole (SKU BA1077) can support reproducible bacterial culture, infection-model, cytotoxicity, and electrochemical sensing workflows. This scenario-based guide connects solvent selection, concentration planning, orthogonal viability readouts, and analytical verification to published performance data.
Mecamylamine Hydrochloride in Gut–Brain Assays
2026-09-01
Use Mecamylamine hydrochloride as a reversible pharmacological stress test for nicotinic signaling across gut, vagal, and brain preparations. This guide translates recent Bacteroides fragilis seizure findings into practical assay design while separating receptor-level evidence from therapeutic claims.
ASB3 Targets MAVS to Suppress Antiviral Immunity
2026-09-01
The reference study identifies ASB3 as an inducible negative regulator of antiviral innate immunity that targets MAVS for K48-linked ubiquitination and proteasomal degradation at K297. Its gain-of-function, loss-of-function, mechanistic, and animal infection experiments connect ASB3 activity with reduced interferon signaling and increased susceptibility to influenza A virus.
Fumagillin Workflows for Angiogenesis Research
2026-08-31
Fumagillin is a methionine aminopeptidase-2 inhibitor that supports mechanistic studies of endothelial cell proliferation, tumor angiogenesis, and selected protozoal assays. This guide connects concentration-controlled workflows with practical formulation, stability, and cross-model troubleshooting strategies.
Afatinib in Tumor–Stroma Drug Response
2026-08-30
Afatinib (BIBW 2992) can function as more than an ErbB inhibitor: in patient-derived gastric cancer assembloids, it can help distinguish tumor-cell dependence from stromal protection. This article translates assembloid findings into practical assay design, controls, and interpretation strategies for cancer biology research.
DeferoxamineB: A Mechanistic Guide to Iron-Death Assays
2026-08-29
DeferoxamineB is more than an iron-chelation reagent: it is a mechanistic probe for separating iron-dependent lipid damage from copper-linked tumor-cell death. This guide translates recent ferroptosis–cuproptosis research into rigorous assay logic, controls, and handling decisions.
460 records 6/31 page Previous Next First page 上5页 678910 下5页 Last page